BR9800323B1 - composição lìquida contendo gonadotropina, processo para preparar a mesma, cartucho, e, dispositivo de administração. - Google Patents

composição lìquida contendo gonadotropina, processo para preparar a mesma, cartucho, e, dispositivo de administração.

Info

Publication number
BR9800323B1
BR9800323B1 BRPI9800323-2A BR9800323A BR9800323B1 BR 9800323 B1 BR9800323 B1 BR 9800323B1 BR 9800323 A BR9800323 A BR 9800323A BR 9800323 B1 BR9800323 B1 BR 9800323B1
Authority
BR
Brazil
Prior art keywords
gonadotropin
cartridge
preparing
same
liquid composition
Prior art date
Application number
BRPI9800323-2A
Other languages
English (en)
Other versions
BR9800323A (pt
Inventor
Arnold Titus Philip Skrabanja
Den Oetellar Petrus Johannes Maria Van
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR9800323A publication Critical patent/BR9800323A/pt
Publication of BR9800323B1 publication Critical patent/BR9800323B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI9800323-2A 1997-01-15 1998-01-14 composição lìquida contendo gonadotropina, processo para preparar a mesma, cartucho, e, dispositivo de administração. BR9800323B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97200099 1997-01-15

Publications (2)

Publication Number Publication Date
BR9800323A BR9800323A (pt) 1999-06-29
BR9800323B1 true BR9800323B1 (pt) 2011-04-19

Family

ID=8227932

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9800323-2A BR9800323B1 (pt) 1997-01-15 1998-01-14 composição lìquida contendo gonadotropina, processo para preparar a mesma, cartucho, e, dispositivo de administração.

Country Status (30)

Country Link
US (1) US5929028A (pt)
EP (2) EP0853945B1 (pt)
JP (1) JP4353549B2 (pt)
KR (1) KR100498531B1 (pt)
CN (1) CN1165341C (pt)
AR (1) AR011410A1 (pt)
AT (1) ATE237348T1 (pt)
AU (1) AU736339B2 (pt)
BR (1) BR9800323B1 (pt)
CA (1) CA2226803A1 (pt)
CZ (1) CZ297419B6 (pt)
DE (2) DE69813322T2 (pt)
DK (1) DK0853945T3 (pt)
ES (1) ES2196474T3 (pt)
FR (1) FR10C0024I2 (pt)
HK (1) HK1010150A1 (pt)
HU (1) HU227154B1 (pt)
ID (1) ID19499A (pt)
IL (1) IL122732A0 (pt)
LU (1) LU91655I2 (pt)
MX (1) MX9800438A (pt)
NO (3) NO322509B1 (pt)
NZ (1) NZ329572A (pt)
PL (1) PL190103B1 (pt)
PT (1) PT853945E (pt)
RU (1) RU2203086C2 (pt)
SA (1) SA98181124B1 (pt)
TR (1) TR199800062A2 (pt)
TW (1) TW518235B (pt)
ZA (1) ZA9883B (pt)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU776823B2 (en) * 1998-07-23 2004-09-23 Ares Trading S.A. FSH and FSH variant formulations, products and methods
US20030166525A1 (en) 1998-07-23 2003-09-04 Hoffmann James Arthur FSH Formulation
JP2007204498A (ja) * 1999-03-01 2007-08-16 Chugai Pharmaceut Co Ltd 長期安定化製剤
JP2000247903A (ja) 1999-03-01 2000-09-12 Chugai Pharmaceut Co Ltd 長期安定化製剤
ATE386501T1 (de) * 1999-07-12 2008-03-15 Sandoz Ag Formulierungen von wachstumshormonen
EA004385B1 (ru) * 2000-02-22 2004-04-29 Апплайд Резеч Системз Арс Холдинг Н.В. Способ выделения лютеинизирующего гормона
US7256184B2 (en) * 2000-10-16 2007-08-14 Rodriguez Victorio C Treatment of aging disorders in humans
AU2007200662A1 (en) * 2001-08-30 2007-03-08 Kirin-Amgen, Inc. L-methionine as a stabilizer for NESP/EPO in HSA-free formulations
US20030104996A1 (en) * 2001-08-30 2003-06-05 Tiansheng Li L-methionine as a stabilizer for NESP/EPO in HSA-free formulations
EP1346843A1 (en) * 2002-03-22 2003-09-24 Fuji Photo Film Co., Ltd. Image forming method
CA2518268C (en) 2003-03-04 2013-12-10 Aspenbio, Inc. Methods and kits for maintaining pregnancy, treating follicular cysts, and synchronizing ovulation using luteinizing hormone
DK1610822T4 (en) 2003-04-02 2019-01-14 Ares Trading Sa Liquid pharmaceutical FSH and LH formulations together with a nonionic surfactant
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
CA2526099C (en) * 2003-06-20 2013-02-05 Ares Trading Sa Freeze-dried fsh / lh formulations
JP4412989B2 (ja) * 2003-12-15 2010-02-10 株式会社日立製作所 複数の記憶システムを有するデータ処理システム
KR100587535B1 (ko) * 2004-02-04 2006-06-08 충남대학교산학협력단 재조합 ｈＦＳＨ 유전자 및 이를 내장하는 발현용 벡터
TWI369401B (en) 2005-07-05 2012-08-01 Ares Trading Sa Serum-free culture medium for the production of recombinant gonadotropins
KR101105871B1 (ko) * 2005-09-27 2012-01-16 주식회사 엘지생명과학 인 난포자극호르몬의 안정한 용액 제형
US8168206B1 (en) 2005-10-06 2012-05-01 Allergan, Inc. Animal protein-free pharmaceutical compositions
US8137677B2 (en) * 2005-10-06 2012-03-20 Allergan, Inc. Non-protein stabilized clostridial toxin pharmaceutical compositions
WO2007056851A1 (en) * 2005-11-17 2007-05-24 Mount Sinai Hospital Compositions and methods for enhancing ovulation inducing agents
US9458444B2 (en) 2006-02-03 2016-10-04 Opko Biologics Ltd. Long-acting coagulation factors and methods of producing same
US10221228B2 (en) 2006-02-03 2019-03-05 Opko Biologics Ltd. Long-acting polypeptides and methods of producing and administering same
US20140113860A1 (en) 2006-02-03 2014-04-24 Prolor Biotech Ltd. Long-acting polypeptides and methods of producing and administering same
US10351615B2 (en) 2006-02-03 2019-07-16 Opko Biologics Ltd. Methods of treatment with long-acting growth hormone
US8450269B2 (en) * 2006-02-03 2013-05-28 Prolor Biotech Ltd. Long-acting growth hormone and methods of producing same
US8048849B2 (en) 2006-02-03 2011-11-01 Modigene, Inc. Long-acting polypeptides and methods of producing same
US9249407B2 (en) 2006-02-03 2016-02-02 Opko Biologics Ltd. Long-acting coagulation factors and methods of producing same
US8946155B2 (en) 2006-02-03 2015-02-03 Opko Biologics Ltd. Long-acting polypeptides and methods of producing and administering same
US20150038413A1 (en) 2006-02-03 2015-02-05 Opko Biologics Ltd. Long-acting polypeptides and methods of producing and administering same
WO2008038817A1 (en) * 2006-09-25 2008-04-03 National University Corporation Tokyo University Of Agriculture And Technology Ultrasonic operation device and microtube inside system
KR20080106636A (ko) * 2007-06-04 2008-12-09 동아제약주식회사 사람 융모성 성선자극호르몬 함유 즉시 사용형 주사 용액
US7951368B2 (en) * 2007-06-25 2011-05-31 Amgen Inc. Compositions of specific binding agents to hepatocyte growth factor
JP5570980B2 (ja) 2007-06-28 2014-08-13 ラティオファーム ゲーエムベーハー Ｆｓｈ生産細胞クローン
JP5551601B2 (ja) * 2007-11-01 2014-07-16 メルク セローノ ソシエテ アノニム Ｌｈ液体調製物
ME01337B (me) * 2008-02-08 2013-12-20 Biogenerix Ag Tečni preparat fsh
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
CN102309745B (zh) * 2008-09-17 2013-05-08 上海天伟生物制药有限公司 一种卵泡刺激素冻干针剂
CN101347613B (zh) * 2008-09-17 2011-10-26 上海天伟生物制药有限公司 几乎不含亚基的糖蛋白的组合物及其制备方法
ES2548378T3 (es) * 2008-11-04 2015-10-16 Aska Pharmaceutical Co., Ltd. Composición acuosa que contiene hormona foliculoestimulante
US9663778B2 (en) 2009-07-09 2017-05-30 OPKO Biologies Ltd. Long-acting coagulation factors and methods of producing same
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
EP2325194A1 (en) 2009-11-24 2011-05-25 Glycotope GmbH Process for the purification of glycoproteins
EP2417982A1 (en) * 2010-07-30 2012-02-15 Ferring B.V. Stabilization of gonadotropins
WO2012127500A2 (en) * 2011-03-11 2012-09-27 Sanzyme Limited Composition for spermatogenesis
WO2012127501A2 (en) * 2011-03-11 2012-09-27 Sanzyme Limited Composition for improving endometrial thickness during ovarian stimulation
EP2691119B1 (en) 2011-03-31 2018-08-01 Ferring B.V. Pharmaceutical preparation
US8680086B2 (en) 2011-04-15 2014-03-25 Neuralight Hd, Llc Methods for chronic pain management and treatment using HCG
US20120265129A1 (en) 2011-04-15 2012-10-18 Neuralight Hd, Llc Methods for Chronic Pain Management and Treatment using HCG
WO2013010840A2 (en) 2011-07-18 2013-01-24 Arts Biologics A/S Long acting biologically active luteinizing hormone (lh) compound
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
BR112014025951A2 (pt) 2012-04-19 2017-07-11 Opko Biologics Ltd variantes de oxintomodulina de longa ação e métodos de produção do mesmo
BR112015008753A2 (pt) 2012-10-18 2017-07-04 Neuralight Hd Llc tratamento de depressão e ptsd
CN112661863A (zh) 2012-11-20 2021-04-16 奥普科生物制品有限公司 通过连接至促性腺激素羧基端肽来增加多肽的流体动力学体积的方法
ES2694328T3 (es) 2013-03-12 2018-12-19 Sumitomo Dainippon Pharma Co., Ltd. Composición acuosa líquida
US20160024181A1 (en) 2013-03-13 2016-01-28 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
US20150158926A1 (en) 2013-10-21 2015-06-11 Opko Biologics, Ltd. Long-acting polypeptides and methods of producing and administering same
IN2013MU03559A (pt) 2013-11-12 2015-07-24 Cadila Healthcare Ltd
SI3209319T1 (sl) * 2014-10-21 2022-01-31 Hexima Limited Postopek zdravljenja glivičnih okužb
EP3310347B1 (en) 2015-06-19 2021-08-04 OPKO Biologics Ltd. Long-acting coagulation factors and methods of producing same
GB201603280D0 (en) * 2016-02-24 2016-04-13 Ferring Bv Stable liquid gonadotropin formulation
KR20240006077A (ko) 2016-07-11 2024-01-12 옵코 바이오로직스 리미티드 지속성 응고 인자 vii 및 그 제조 방법
EP3436054B2 (en) 2016-09-13 2022-07-27 Allergan, Inc. Stabilized non-protein clostridial toxin compositions
US11110063B2 (en) 2017-08-25 2021-09-07 MAIA Pharmaceuticals, Inc. Storage stable sincalide formulations
BR112021022860A2 (pt) 2019-05-16 2022-01-18 Ceva Sante Animale Composições e métodos para aumentar o desempenho da reprodução em mamíferos não humanos com uso de hormônio luteinizante recombinante
CN114404575A (zh) * 2020-12-07 2022-04-29 苏州智核生物医药科技有限公司 一种重组人促甲状腺素注射液
CN117783545A (zh) * 2023-12-28 2024-03-29 深圳市新产业生物医学工程股份有限公司 经封闭剂封闭的软质材料、容器、液态校准品及检测试剂盒

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4357934A (en) * 1980-07-23 1982-11-09 The Curators Of The University Of Missouri Method of treating male infertility
US4457916A (en) * 1982-08-31 1984-07-03 Asahi Kasei Kogyo Kabushiki Kaisha Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
IT1206302B (it) * 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario
US5997856A (en) * 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
JP3045539B2 (ja) * 1989-02-21 2000-05-29 ワシントン ユニバーシティ 改変型生殖ホルモン
US5338835A (en) * 1989-02-21 1994-08-16 Washington University CTP-extended form of FSH
US5114948A (en) * 1989-10-19 1992-05-19 Eli Lilly And Company Stabilized pergolide compositions
IE64738B1 (en) * 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
US5384132A (en) * 1990-03-20 1995-01-24 Akzo N.V. Stabilized gonadotropin containing preparations
US5272135A (en) * 1991-03-01 1993-12-21 Chiron Ophthalmics, Inc. Method for the stabilization of methionine-containing polypeptides
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
CA2133205C (en) * 1992-04-30 2007-04-17 Robert L. Swift Stable polypeptide composition
US5281198A (en) * 1992-05-04 1994-01-25 Habley Medical Technology Corporation Pharmaceutical component-mixing delivery assembly
EP0814841B1 (en) * 1995-03-21 2001-12-05 Applied Research Systems ARS Holding N.V. Hcg liquid formulations

Also Published As

Publication number Publication date
DK0853945T3 (da) 2003-08-04
PL324279A1 (en) 1998-07-20
RU2203086C2 (ru) 2003-04-27
CN1191139A (zh) 1998-08-26
FR10C0024I1 (pt) 2010-05-21
HU9800056D0 (en) 1998-03-02
DE69813322D1 (de) 2003-05-22
NO980177L (no) 1998-07-16
IL122732A0 (en) 1998-08-16
ZA9883B (en) 1998-07-08
DE122010000011I1 (de) 2010-07-08
EP0853945B1 (en) 2003-04-16
PL190103B1 (pl) 2005-10-31
NZ329572A (en) 1999-05-28
JPH10203997A (ja) 1998-08-04
NO2021001I1 (no) 2021-01-12
ES2196474T3 (es) 2003-12-16
HU227154B1 (en) 2010-08-30
AU5205998A (en) 1998-07-23
PT853945E (pt) 2003-08-29
NO2010013I1 (no) 2010-06-07
HUP9800056A2 (hu) 1998-08-28
LU91655I2 (fr) 2010-04-26
NO980177D0 (no) 1998-01-14
CA2226803A1 (en) 1998-07-15
CZ13598A3 (cs) 1998-08-12
AR011410A1 (es) 2000-08-16
MX9800438A (es) 1998-11-30
EP1285665A1 (en) 2003-02-26
BR9800323A (pt) 1999-06-29
TR199800062A2 (xx) 1998-08-21
US5929028A (en) 1999-07-27
NO2010013I2 (no) 2015-05-18
NO322509B1 (no) 2006-10-16
EP0853945A1 (en) 1998-07-22
ATE237348T1 (de) 2003-05-15
AU736339B2 (en) 2001-07-26
JP4353549B2 (ja) 2009-10-28
HK1010150A1 (en) 1999-06-17
HUP9800056A3 (en) 2001-01-29
KR19980070493A (ko) 1998-10-26
FR10C0024I2 (fr) 2011-04-01
CN1165341C (zh) 2004-09-08
KR100498531B1 (ko) 2005-09-30
CZ297419B6 (cs) 2006-12-13
TW518235B (en) 2003-01-21
SA98181124B1 (ar) 2006-07-10
DE69813322T2 (de) 2004-02-19
ID19499A (id) 1998-07-16

Similar Documents

Publication Publication Date Title
BR9800323B1 (pt) composição lìquida contendo gonadotropina, processo para preparar a mesma, cartucho, e, dispositivo de administração.
BR9804504B1 (pt) isoquinolina-3-carboxamidas substituÍdas, processo para a preparaÇço das mesmas e medicamento.
BR9810802B1 (pt) composto, composição farmacêutica, e, processo para a preparação de um composto.
BR9911123B1 (pt) compostos derivados de diàxido de benzotiepina-1,1, processo para sua preparaÇço e seu uso, medicamentos contendo-os e processo para a preparaÇço desses.
BR9807814B1 (pt) composto de pirazina, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
BR9813857B1 (pt) Processo para a preparação de um desinfetante aquoso, e, desinfetante aquoso.
BR9808422B1 (pt) composto, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
BR9803720B1 (pt) composto de pigmento de quinoxalina-monoazo-acetarilida, processo para a preparação e uso do mesmo.
BR9802491B1 (pt) emulsço méltipla estavael, e, processo para formar a mesma.
BR9810552B1 (pt) composição depilatória, processo para preparar a mesma, e, uso da mesma.
BR9906373B1 (pt) compostos pirimidinona, composições farmacêuticas contendo os compostos e processos para a preparação dos mesmos.
BR9807682B1 (pt) composto, uso do mesmo, composiÇço farmacÊutica, e, processos para preparar um composto.
BR9800928B1 (pt) material cosmético, e, processo para preparar o mesmo.
BR9713912B1 (pt) composição inseticida e miticida, e, processo para a preparação da mesma.
BR9805390B1 (pt) processo para preparação de 2-(metilsulfonil)-5-trifluormetil)-1,3,4-tiadiazol.
ES1029208Y (es) Cartucho contenedor de infusiones, para cafeteras.
ES1034872Y (es) Aplicador para medicamentos.
NO952426D0 (no) Nytt legemiddel som inneholder 3,7-diazabisyklo[3,3,1Ånonan forbindelser
ES1039082Y (es) Recipiente perfeccionado para liquidos.
ES1036498Y (es) Empapador reutilizable, para incontinencias.
ES1030228Y (es) Envase perfeccionado para conservas.
ES1036679Y (es) Dispositivo para sanitarios.
ES1037169Y (es) Dispositivo para podologia.
ES1010127Y (es) Envase no recuperable, para jeringuillas.
ES1038272Y (es) Envase expositor, inviolable, perfeccionado.

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: N.V. ORGANON (NL)

Free format text: TRANSFERIDO DE: AKZO NOBEL N.V.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/04/2011, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved
B25A Requested transfer of rights approved
B25A Requested transfer of rights approved
B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 19.04.2021